Clinical Trials Directory

Trials / Completed

CompletedNCT05200195

Deep Learning Model for the Prediction of Post-LT HCC Recurrence

Development and Validation of a Deep Learning Model for the Prediction of Hepatocellular Cancer Recurrence After Transplantation: The Time-Radiological Response- AlphafetoproteIN-Artificial Intelligence Model

Status
Completed
Phase
Study type
Observational
Enrollment
4,026 (actual)
Sponsor
European Hepatocellular Cancer Liver Transplant Group · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Identifying patients at high risk for recurrence of hepatocellular carcinoma (HCC) after liver transplantation (LT) represents a challenging issue. The present study aims to develop and validate an accurate post-LT recurrence prediction calculator using the machine learning method.

Detailed description

In 1996, the introduction of the Milan criteria (MC) strongly modified the selection process of hepatocellular cancer (HCC) patients waiting for liver transplantation (LT). Many attempts to widen MC have been proposed. Initially, exclusively morphology-based (nodules number and target lesion diameter) criteria were created. In the last years, extended criteria also based on biological parameters have been added. Among the most adopted biology-based features, the levels of different tumor markers, liver function parameters like the model for end-stage liver disease (MELD), the radiological response after neo-adjuvant therapies, and the length of waiting-time (WT) can be reported. Unfortunately, all the proposed models showed suboptimal prediction abilities for the risk of post-LT recurrence. Such impairment was derived from the limitations of the standard statistical methods to account for many variables and their non-linear interactions. Therefore, developing a model based on Artificial Intelligence (AI) represents an attractive way to improve prediction ability. Thus, the investigators hypothesize that an AI model focused on an accurate post-transplant HCC recurrence prediction should improve our ability to pre-operatively identify patients with different classes of risk for HCC recurrence after transplant. This study aims to develop an AI-derived prediction model combining morphology and biology variables. A Training Set derived from an International Cohort was adopted for doing this. A Test Set derived from the same International Cohort and a Validation Cohort were adopted for the internal and external validation, respectively. A user-friendly web calculator was also developed.

Conditions

Interventions

TypeNameDescription
PROCEDURELiver transplantationDeceased or living donor liver transplantation for the cure of hepatocellular cancer on cirrhosis

Timeline

Start date
2020-01-15
Primary completion
2021-12-15
Completion
2022-03-15
First posted
2022-01-20
Last updated
2022-06-30

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05200195. Inclusion in this directory is not an endorsement.